Stock Events

Stock Events

Neuronetics 

€1.85
42
+€0.13+7.58% Tuesday 19:55

Statistics

Day High
1.9
Day Low
1.72
52W High
4.11
52W Low
1.02
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4AugExpected
Q4 2025
Q1 2026
Next
-0.15
-0.13
-0.11
-0.09
Expected EPS
-0.10616171599999999
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NRC.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Minerva Neurosciences
NERV
Mkt Cap266.12M
Minerva Neurosciences, works on treatments for central nervous system diseases, indirectly competing with Neuronetics' psychiatric focus.
LivaNova
LIVN
Mkt Cap3.35B
LivaNova PLC, a medical device company with products in neuromodulation, directly competes in the neurostimulation market.
Masimo
MASI
Mkt Cap9.35B
Masimo Corporation, while focused on monitoring technologies, has ventured into brain function monitoring, indirectly competing.
Medtronic
MDT
Mkt Cap102.71B
Medtronic, a large diversified medical device company, has a neuromodulation division that competes in the neurostimulation market.

About

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Show more...
CEO
Mr. Daniel L. Reuvers
Employees
716
Country
United States
ISIN
US64131A1051

Listings

STU
DE
NRC.STU
MU
DE
NRC.MU
BOATS
BOATS
STIM.BOATS
XNAS
US
STIM

0 Comments

Share your thoughts

FAQ

What is Neuronetics stock price today?▼
The current price of NRC.STU is €1.85 EUR — it has increased by +7.58% in the past 24 hours. Watch Neuronetics stock price performance more closely on the chart.
What is Neuronetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neuronetics stocks are traded under the ticker NRC.STU.
Is Neuronetics stock price growing?▼
NRC.STU stock has risen by +29.02% compared to the previous week, the month change is a +40.62% rise, over the last year Neuronetics has showed a -51.32% decrease.
When is the next Neuronetics earnings date?▼
Neuronetics is going to release the next earnings report on August 04, 2026.
What were Neuronetics earnings last quarter?▼
NRC.STU earnings for the last quarter are -0.14 EUR per share, whereas the estimation was -0.15 EUR resulting in a +8.2% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Neuronetics have?▼
As of May 06, 2026, the company has 716 employees.
In which sector is Neuronetics located?▼
Neuronetics operates in the Health & Wellness sector.
When did Neuronetics complete a stock split?▼
Neuronetics has not had any recent stock splits.
Where is Neuronetics headquartered?▼
Neuronetics is headquartered in Malvern, United States.